MULTIPLE SCLEROSIS
![Foto de MULTIPLE SCLEROSIS](/img/grupo.png)
![Foto de Complejo Hospitalario Torrecárdenas de Almería](/img/noimage_org.png)
Complejo Hospitalario Torrecárdenas de Almería
Almería, EspañaPublications in collaboration with researchers from Complejo Hospitalario Torrecárdenas de Almería (3)
2024
-
Clinical characteristics and impact on patient-reported outcomes and quality of life of people with ambulatory secondary progressive multiple sclerosis: Discover study
Multiple Sclerosis and Related Disorders, Vol. 90
2021
-
The age again in the eye of the COVID-19 storm: evidence-based decision making
Immunity and Ageing, Vol. 18, Núm. 1
2015
-
Lipid-specific immunoglobulin M bands in cerebrospinal fluid are associated with a reduced risk of developing progressive multifocal leukoencephalopathy during treatment with natalizumab
Annals of Neurology, Vol. 77, Núm. 3, pp. 447-457